October 2002 Cover
|
 |
Advanced AIDS patients who have become resistant to treatment with all available HIV drugs might benefit from strictly controlled treatment interruptions, Dr. Christine Katlama
of Hospital Pitie-Salpetriere in Paris said at the 14th International AIDS Conference. Katlama said taking these patients off their medications for a period of eight weeks in a
well-monitored hospital setting made the virus in their bloodstream susceptible to drug treatment once again.
Structured treatment interruptions are a subject of debate among AIDS researchers. With results of several studies mixed, however, most researchers think the approach
cannot currently be recommended except under closely monitored conditions.
The French team studied a group of 68 patients who had exhausted all currently available HIV drug therapies. Eligible patients had to have more than 50,000 copies of the virus
per milliliter of blood and CD4 counts below 200 cells per microliter. Half the study group were immediately given a "salvage" therapy including as many as nine antiretroviral drugs,
while the other half were given an eight-week break before starting the rescue treatment.
More than half of the patients in the deferred treatment group became responsive to at least one class of drugs they had previously been resistant to, Katlama
reported. Interrupting the treatment seemed to have no adverse effects, she added, but the patients were already very sick.
The amount of virus in the blood of patients who did not have treatment interruption remained constant for 24 weeks after the study began. In contrast, viral levels in those
who had a break in treatment dropped by a factor of ten after 24 weeks of resumed drug therapy.
Editor's Note: from Reuters Health
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
